- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03186703
Evaluating the Impact of the McMaster Optimal Aging Portal on Cancer Prevention Behaviours in Underserved Populations
Evaluating the Impact of the McMaster Optimal Aging Portal on Knowledge, Behavioural Intentions and Health Behaviours Related to Cancer Risk in Underserved Populations.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Half of cancers are preventable through lifestyle modification such as smoking cessation, healthy eating, increasing physical activity and reducing alcohol intake; however, few Canadians engage in behaviours that are in line with cancer prevention guidelines. This may be in part due to lack of access to evidence-based information and the mixed messages on effective cancer prevention strategies that are propagated in the popular media.
The McMaster Optimal Aging Portal (the Portal) is a knowledge translation (KT) tool launched in 2014 to increase public access to trustworthy health information. Citizen-friendly content (blog posts, evidence summaries, web resource ratings) provide easy-to-read 'bottom line' messages appropriate for all audiences. Investigators would now like to know if and how KT strategies used to disseminate citizen-targeted information on cancer prevention impact knowledge, behavioural intentions and health behaviours of Canadian adults.
This study will use a sequential mixed-methods design consisting of a two-arm randomized controlled trial (RCT) and a qualitative process study to explore RCT findings in depth. This formative approach will allow for a deeper analysis of the outcomes of interest (knowledge, intentions and behaviours), and the KT process. Following baseline data collection, eligible participants will be randomized to a 12-week intervention or control group.
During the intervention, participants will have access to the Portal, be invited to follow a Twitter and Facebook feed, and receive tailored weekly email alerts including blog posts and evidence summaries on cancer prevention. Control group participants will have access the Portal in a 'self-serve' fashion, but will not receive KT strategies.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8P0A1
- McMaster University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- English speaking
Exclusion Criteria:
- Previous cancer diagnosis
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Tailored knowledge translation
During the 12-week intervention, intervention group participants will have access to the Portal and will receive targeted weekly email alerts including blog posts and evidence summaries relevant to cancer prevention and be invited to follow a Twitter and Facebook feed; a unique hashtag will be created to identify and collate relevant cancer prevention information.
|
Tailored knowledge translation strategies specific to evidence-based cancer prevention recommendations
|
|
NO_INTERVENTION: Control
Participants in the control group will have access to the Portal in a 'self-serve' fashion.
These participants will be able to browse the Portal, subscribe to email alerts, follow social media, etc. but will not receive the tailored intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Website engagement
Time Frame: 12 weeks
|
Number of clicks
|
12 weeks
|
|
Email engagement
Time Frame: 12 weeks
|
Number of clicks
|
12 weeks
|
|
Social media engagement
Time Frame: 12 weeks
|
Number of clicks
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge questionnaire
Time Frame: 12 weeks, 3-months post-intervention
|
Participants knowledge of cancer prevention recommendations and guidelines
|
12 weeks, 3-months post-intervention
|
|
Beliefs questionnaire
Time Frame: 12 weeks, 3-months post-intervention
|
Participants beliefs about the importance of lifestyle in prevention cancer
|
12 weeks, 3-months post-intervention
|
|
Intentions questionnaire
Time Frame: 12 weeks, 3-months post-intervention
|
Participants intentions to engage in lifestyle behaviours in line with cancer prevention guidelines
|
12 weeks, 3-months post-intervention
|
|
Godin leisure time exercise questionnaire
Time Frame: 12 weeks, 3 months post-intervention
|
Physical activity
|
12 weeks, 3 months post-intervention
|
|
Dietary Screener Questionnaire
Time Frame: 12 weeks, 3 months post-intervention
|
Dietary intake
|
12 weeks, 3 months post-intervention
|
|
Tobacco Questions for Surveys, World Health Organization
Time Frame: 12 weeks, 3 months post-intervention
|
Current smoking behaviour
|
12 weeks, 3 months post-intervention
|
|
Seven-day recall alcohol
Time Frame: 12 weeks, 3 months post-intervention
|
Alcohol intake
|
12 weeks, 3 months post-intervention
|
|
Participant satisfaction
Time Frame: 12 weeks
|
Collected using qualitative interviews
|
12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 316590
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Second Affiliated Hospital of Soochow UniversityNot yet recruitingCancer | Solid Cancer
-
New Mexico Cancer Research AllianceOhio State University Comprehensive Cancer Center; H. Lee Moffitt Cancer Center...RecruitingCancer | Cancer RiskUnited States
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
Clinical Trials on Tailored knowledge translation
-
McMaster UniversityCompletedMobility LimitationCanada
-
Sunnybrook Health Sciences CentreScarborough General Hospital; Michael Garron Hospital; York Central Hospital,... and other collaboratorsCompleted
-
Montreal General HospitalSanofi; Canadian Institutes of Health Research (CIHR); Fonds de la Recherche...CompletedAcute Coronary Syndromes
-
University of PisaNational Health and Medical Research Council, Australia; European CommissionEnrolling by invitation
-
University of ManitobaCanadian Primary Care Sentinel Surveillance Network; Canadians Seeking Solutions... and other collaboratorsTerminated
-
Toronto Rehabilitation InstituteMcGill UniversityUnknown
-
Sunnybrook Health Sciences CentreOntario Ministry of Health and Long Term Care; Sault Area Hospital; Scarborough... and other collaboratorsCompletedCatheter Related Blood Stream Infections | Ventilator Acquired Pneumonia | Pressure Ulcer Prophylaxis | DVT Prophylaxis | Restrictive Blood Transfusion Strategy | Daily Spontaeous Breathing TrialsCanada
-
Dignitas InternationalUniversity of Toronto; Ministry of Health and Population, MalawiCompleted
-
McMaster UniversityMcMaster UniversityCompleted
-
University of ManitobaUniversity of British Columbia; McGill University; University of Toronto; University... and other collaboratorsCompleted